Craniopharyngioma in a patient with acromegaly due to a pituitary macroadenoma

We present the first reported case of a craniopharyngioma as a second primary tumor in a patient with acromegaly due to a growth hormone (GH)-secreting pituitary adenoma. The patient was lost for follow-up for 18 years after trans-sphenoidal pituitary surgery for a GH-secreting pituitary adenoma. She presented with headaches and decreased visual acuity, and showed unsuppressed GH in an oral glucose load test with high IGF-1 levels. Brain MRI showed a suprasellar cystic mass and the patient underwent surgery for cyst drainage resulting in postoperative improvement in her vision. Biopsy of the mass confirmed the diagnosis of a craniopharyngioma. We stress the need for close follow-up of patients with acromegaly with adequate control of GH and IGF-1 levels.  
Source: Annals of Saudi Medicine - Category: General Medicine Tags: ISSUE 6 Source Type: research

Related Links:

VITAMIN B12 deficiency can result in anaemia, but among its symptoms are headaches and a reduced appetite. The vitamin is vital in keeping the body in the best condition, but because the body doesn ’t make the vitamin it’s important to get it from a balanced diet. Here are six foods that are all good sources of B12.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
There is an important scientific fact that we need to be aware of as the political drama at the border unfolds: when children are separated from their parents, they can be damaged for the rest of their lives. Research shows that when children face strong, frequent, or prolonged adversity without adequate support from adults, it causes a stress response that can have terrible consequences. This “toxic stress” affects both the mind and the body. It disrupts normal brain development, leading to not just emotional problems, but problems with thinking and learning. Children who are exposed to toxic stress have a hig...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Children's Health Source Type: blogs
Plus, what you can do about them.
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
AbstractThe identification of anaplastic lymphoma kinase rearrangements in 2 –5% of patients with non-small-cell lung cancer led to rapid advances in the clinical development of oral tyrosine kinase inhibitors. Anaplastic lymphoma kinase inhibitors are an effective treatment in preclinical models and patients with anaplastic lymphoma kinase-translocated cancers. Four anapl astic lymphoma kinase inhibitors (crizotinib, ceritinib, alectinib, and brigatinib) have recently been approved. Post-marketing studies provided additional pharmacokinetic information on their pharmacokinetic parameters. The pharmacokinetic propert...
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
AbstractLisdexamfetamine dimesylate (lisdexamfetamine; Elvanse®; Tyvense®), an orally-active dexamfetamine prodrug, is indicated in the EU for the treatment of attention-deficit hyperactivity disorder (ADHD) in children aged  ≥ 6 years (including adolescents) when the response to previous methylphenidate (MPH) treatment is clinically inadequate. The original approval of the drug was based on the results of phase III trials in children and adolescents with ADHD who had an inadequate response to previous pharmacoth erapy (e.g. MPH) or were treatment naïve. In these studies, short-term treat...
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
AbstractPurpose of reviewAs cancer survivor rates improve with early screening and modern treatment options, cardiotoxicity is becoming an increasing problem. It is imperative for physicians to recognize adverse events early so that appropriate measures can be taken before advanced and permanent cardiac dysfunction ensues. In this review, we will evaluate the literature surrounding current cardiac biomarkers in the detection of cardiotoxicity during cancer treatment as well as discuss the role of emerging novel biomarkers.Recent findingsTroponin and brain natriuretic peptides show promise in the detection of subclinical ca...
Source: Current Treatment Options in Cardiovascular Medicine - Category: Cardiology Source Type: research
This study is a double-blind, placebo-controlled trial at 150 sites in 35 countries. We enrolled patients aged 18 years or older with active rheumatoid arthritis for 3 months or longer, who had received csDMARDs for at least 3 months with a stable dose for at least 4 weeks before study entry, and had an inadequate response to at least one of the following csDMARDs: methotrexate, sulfasalazine, or leflunomide. Using interactive response technology, we randomly assigned patients receiving stable background csDMARDs (2:2:1:1) to receive a once-daily extended-release formulation of upadacitinib 15 mg or 30 mg, or placebo, for ...
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: Available online 18 June 2018 Source:Journal of Pharmacological Sciences Author(s): Namkwon Kim, Jimin Do, Jae-sung Bae, Hee Kyung Jin, Jong-Ho Kim, Kyung-Soo Inn, Myung Sook Oh, Jong Kil Lee Inflammatory processes in the central nervous system are feature among biological reactions to harmful stimuli such as pathogens and damaged cells. In resting conditions, microglia are involved in immune surveillance and brain homeostasis. However, the activation of abnormal microglia can be detrimental to neurons, even resulting in neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s dise...
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
In conclusion, IDH-Mut/Codel tumors were characterized by calcification, frontal location, heterogeneous signal intensity, and cortical invasion; IDH-Mut tumors differed from IDH-Wt tumors according to predominant frontal lobe location and less frequent dense enhancement patterns.
Source: Brain Tumor Pathology - Category: Neurology Source Type: research
ConclusionsEncouraging results for the treatment with BoNT-A in rCCH patients were observed in our study population.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Acromegaly | Brain | Brain Cancers | Craniopharyngioma | General Medicine | Headache | Hormones | Middle East Health | Neurology | Saudi Arabia Health